## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -2.8% below STRENGTH zone (3.0-6.0%); PEG 1.60 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Colgate-Palmolive (CL) Upgraded to Outperform, Target Price Rais**
- Source: GuruFocus | 20251209T200258 | Bullish | Relevance: 99%
-  RBC Capital Markets has upgraded Colgate-Palmolive (CL) to "Outperform" and raised its target price by 18% to $88, citing the company's consistent organic sales growth and effective management strategies despite global economic challenges. The report highlights Colgate-Palmolive's strong market position in household and personal care, robust international sales, and ownership of Hill's pet food. While noting a declining operating margin and high debt-to-equity ratio as warning signs, the analysis suggests a stable outlook with potential for growth, supported by a strong Altman Z-Score and positive analyst sentiment.

**2. SVB Wealth LLC Takes Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251209T140759 | Somewhat-Bullish | Relevance: 99%
-  SVB Wealth LLC recently acquired a new stake in Colgate-Palmolive Company, purchasing 19,596 shares valued at approximately $1.78 million in Q2. This move aligns with other large institutional investors like Vanguard and Norges Bank, bringing total institutional ownership to 80.41%. Despite recent analyst price target reductions, the consensus remains a "Moderate Buy" for Colgate-Palmolive, with its stock trading near $76.11.

**3. ধারাবাহিক বিনিয়োগকারীদের মনোযোগ আকর্ষণ করছে**
- Source: MarketBeat | 20251208T085229 | Neutral | Relevance: 99%
-  Edgestream Partners L.P. significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 78.9% in the second quarter, selling 15,614 shares and retaining 4,175 shares valued at approximately $380,000. Despite this, institutional investors collectively hold about 80.41% of the company's stock. Colgate-Palmolive reported strong quarterly earnings of $0.91 EPS, beating estimates, and maintains a "Moderate Buy" consensus analyst rating with an average price target of $89.87.

**4. Colgate-Palmolive shares rise as RBC upgrades to 'outperform'**
- Source: TradingView | 20251209T093827 | Bullish | Relevance: 98%
-  Shares of Colgate-Palmolive rose nearly 1% after RBC Capital Markets upgraded the stock rating to "outperform" from "sector perform." RBC cited low current expectations and a favorable setup for the company to return to long-term growth, despite a challenging global environment for consumer staples. The brokerage noted Colgate-Palmolive's resilience, delivering 24 straight quarters of organic sales growth at or above their long-term algorithm.

**5. Ossiam Boosts Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251208T115104 | Somewhat-Bullish | Relevance: 98%
- Ossiam significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 1,874.7% in Q2, bringing its total holdings to 318,692 shares valued at approximately $28.97 million. Other major institutional investors like Vanguard, T. Rowe Associates, Norges Bank, Invesco, and Ameriprise Financial also increased their positions, resulting in institutional investors owning about 80.41% of the stock. Colgate-Palmolive reported stronger-than-expected quarterly EPS of $0.91 and a $0.52 quarterly dividend, and holds a consensus analyst rating of "Moderate Buy" with a target price of $89.87.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.07M) |
| Sells | 23 ($1.66M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Long-term trend broken: trading 10.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.60 elevated, pricing in significant growth expectations. Forward P/E 20.0x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Insider selling cluster ($1.7M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $62.2B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.60 |
| Forward P/E | 20.0 |
| Current P/E | 21.0 |
| YoY Growth | 5.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 5.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.82% (CS: 27) | Weak |
| RSI_14 | 43.2 | Neutral |
| MACD Histogram | -0.32 | Bearish |
| vs SMA20 | 0.977x | Below |
| vs SMA50 | 0.984x | Below |
| vs SMA200 | 0.893x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $76.98
- **Stop Loss:** $74.04 (3.8% risk)
- **Target:** $79.92 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 170
- **Position Value:** $13,086.60
- **Portfolio %:** 13.09%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*